TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2023
Voltar para busca
Dado oficial do USPTO
AFFIMED
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
06/10/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
24/07/2019
Data de registro
07/12/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/12/2021
Última transação
06/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Mannheim, DE
Examinador
ROSEN, BENJAMIN
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Affimed GmbH
Affimed GmbH
Representantes
Shauna M. Wertheim THE MARBURY LAW GROUP, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biological and biochemical preparationsin particular in form of antibodiesantibody derivativesbinding proteins and peptides for laboratory and experimentation purposesin particular for conducting experimental assaysother than for medical or veterinary purposes; biological and biochemical diagnostic preparations other than for medical or veterinary purposesin particular in form of antibodiesantibody derivativesbinding proteins and peptides
Classe 5
Pharmaceutical and veterinary preparations for cancer and immuno-oncology; biological and biochemical preparations for the treatment of cancer in form of antibodiesantibody derivativesbinding proteins and peptides for medical or veterinary purposes; biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cellsin particular with binding affinity to T cells and natural killer (NK) cellsin particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic use for medical or veterinary purposesin particular in form of antibodiesantibody derivativesbinding proteins and peptides; biological and biochemical preparations for the treatment of cancer in form of antibodiesantibody derivativesbinding proteins and peptides for use within the framework of experimental and medical or veterinary assays; biological and biochemical diagnostic preparations for medical or veterinary use in form of antibodiesantibody derivativesbinding proteins and peptides for use within the framework of medical or veterinary assays
Classe 42
Scientific and technological servicesresearch and design in the field of immuno-therapyin particular in the field of immuno-oncology; scientific and technological servicesresearch and design in the field of virology; scientific and technological servicesresearch and design in the field of antiinfectives; scientific and technological servicesresearch and design in the field of neurodegenerative diseases; scientific and technological servicesresearch and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodiesantibody derivativesbinding proteins and peptides; scientific and technological servicesresearch and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunityin particular in the field of immune-oncology
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/12/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
03/11/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
23/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/08/2021
PUBO
PUBLISHED FOR OPPOSITION
24/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/07/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
20/07/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
29/05/2021
GNSL
LETTER OF SUSPENSION E-MAILED
29/05/2021
CNSL
SUSPENSION LETTER WRITTEN
29/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/05/2021
ALIE
ASSIGNED TO LIE
28/05/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/03/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/09/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/09/2020
CNSI
SUSPENSION INQUIRY WRITTEN
07/09/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/03/2020
GNSL
LETTER OF SUSPENSION E-MAILED
07/03/2020
CNSL
SUSPENSION LETTER WRITTEN
07/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2020
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
22/10/2019
GPRA
PRIORITY ACTION E-MAILED
22/10/2019
CPRA
PRIORITY ACTION WRITTEN
22/10/2019
DOCK
ASSIGNED TO EXAMINER
15/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2019
NWAP
NEW APPLICATION ENTERED
29/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AFFIMED ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.